{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T15:26:29Z","timestamp":1767972389019,"version":"3.49.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T00:00:00Z","timestamp":1523232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,1]]},"DOI":"10.1093\/jjco\/hyy046","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T08:39:34Z","timestamp":1521707974000},"page":"442-449","source":"Crossref","is-referenced-by-count":6,"title":["A double-blind, randomized comparative study to investigate the morphine to hydromorphone conversion ratio in Japanese cancer patients"],"prefix":"10.1093","volume":"48","author":[{"given":"Satoshi","family":"Inoue","sequence":"first","affiliation":[{"name":"Clinical Development Department, R&D Division, Daiichi Sankyo Co., Ltd"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Shimane University Faculty of Medicine, Shimane"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Tsuneto","sequence":"additional","affiliation":[{"name":"Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuko","family":"Aruga","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, Teikyo University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Ogata","sequence":"additional","affiliation":[{"name":"Clinical Development Department, R&D Division, Daiichi Sankyo Co., Ltd"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsutoshi","family":"Uemori","sequence":"additional","affiliation":[{"name":"Biostatistics & Data Management Department, R&D, Daiichi Sankyo Co., Ltd, Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,4,9]]},"reference":[{"key":"key\n\t\t\t\t20180830004434_hyy046C1","volume-title":"Cancer Pain Relief: With a Guide to Opioid Availability","author":"World Health Organization","year":"1996","edition":"2nd edn"},{"key":"key\n\t\t\t\t20180830004434_hyy046C2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0304-3959(95)00017-M","article-title":"Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study","volume":"63","author":"Zech","year":"1995","journal-title":"Pain"},{"key":"key\n\t\t\t\t20180830004434_hyy046C3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/15360288.2014.941132","article-title":"An examination of global and regional opioid consumption trends 1980\u2013\u2013011","volume":"28","author":"Hastie","year":"2014","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"key\n\t\t\t\t20180830004434_hyy046C4","author":"International Narcotics Control Board REPORT","year":"2013"},{"key":"key\n\t\t\t\t20180830004434_hyy046C5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1054\/bjoc.2001.1680","article-title":"Morphine and alternative opioids in cancer pain: the EAPC recommendations","volume":"84","author":"Hanks","year":"2001","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20180830004434_hyy046C6","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC","volume":"13","author":"Caraceni","year":"2012","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20180830004434_hyy046C7","doi-asserted-by":"crossref","first-page":"vii139","DOI":"10.1093\/annonc\/mds233","article-title":"Management of cancer pain: ESMO Clinical Practice Guidelines","volume":"23","author":"Ripamonti","year":"2012","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t20180830004434_hyy046C8","author":"National Comprehensive Cancer Network","year":"2012"},{"key":"key\n\t\t\t\t20180830004434_hyy046C9","author":"Johnson","year":"2007"},{"key":"key\n\t\t\t\t20180830004434_hyy046C10","volume-title":"Oxford Textbook of Palliative Medicine","author":"Hanks","year":"2010","edition":"4th edn"},{"key":"key\n\t\t\t\t20180830004434_hyy046C11","volume-title":"Palliative Care Formulary","author":"Twycross","year":"2014","edition":"5th edn"},{"key":"key\n\t\t\t\t20180830004434_hyy046C12","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/(SICI)1097-0142(19960815)78:4<852::AID-CNCR23>3.0.CO;2-T","article-title":"Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine","volume":"78","author":"Bruera","year":"1996","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180830004434_hyy046C13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3959(97)00018-3","article-title":"Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study","volume":"72","author":"Lawlor","year":"1997","journal-title":"Pain"},{"key":"key\n\t\t\t\t20180830004434_hyy046C14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0885-3924(02)00390-1","article-title":"Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain","volume":"23","author":"Palangio","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"key\n\t\t\t\t20180830004434_hyy046C15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/147323000803600218","article-title":"Conversion from standard opioid therapy to once-daily oral extended-release hydromorphone in patients with chronic cancer pain","volume":"36","author":"Wallace","year":"2008","journal-title":"J Int Med Res"},{"key":"key\n\t\t\t\t20180830004434_hyy046C16","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.ajp.0000210925.33783.4d","article-title":"Managing cancer pain and symptoms of outpatients by rotation to sustained-release hydromorphone: a prospective clinical trial","volume":"22","author":"Wirz","year":"2006","journal-title":"Clin J Pain"},{"key":"key\n\t\t\t\t20180830004434_hyy046C17","first-page":"1","article-title":"A randomized crossover comparison of controlled release hydromorphone tablets with controlled release morphine tablets in patients with cancer pain","volume":"2","author":"Moriarty","year":"1999","journal-title":"J Clin Res"},{"key":"key\n\t\t\t\t20180830004434_hyy046C18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.clinthera.2006.01.010","article-title":"Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone administered every 24 hours to patients with persistent moderate to severe pain","volume":"28","author":"Weinstein","year":"2006","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t20180830004434_hyy046C19","author":"Mallinckrodt Brand Pharmaceuticals"},{"key":"key\n\t\t\t\t20180830004434_hyy046C20","author":"JANSSEN-CILAG Pty Ltd"},{"key":"key\n\t\t\t\t20180830004434_hyy046C21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ctrv.2006.03.001","article-title":"Opioid switching: a systematic and critical review","volume":"32","author":"Mercadante","year":"2006","journal-title":"Cancer Treat Rev"},{"key":"key\n\t\t\t\t20180830004434_hyy046C22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/jjco\/hyn010","article-title":"Advisory Committee for Oxycodone Study. Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trial","volume":"38","author":"Narabayashi","year":"2008","journal-title":"Jpn J Clin Oncol"},{"key":"key\n\t\t\t\t20180830004434_hyy046C23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00520-005-0843-2","article-title":"No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients","volume":"14","author":"Riley","year":"2006","journal-title":"Support Care Cancer"},{"key":"key\n\t\t\t\t20180830004434_hyy046C24","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/0269216310384902","article-title":"European Palliative Care Research Collaborative pain guidelines: opioid switching to improve analgesia or reduce side effects. A systematic review","volume":"25","author":"Dale","year":"2011","journal-title":"Palliat Med"},{"key":"key\n\t\t\t\t20180830004434_hyy046C25","author":"Napp Pharmaceuticals Limited"},{"key":"key\n\t\t\t\t20180830004434_hyy046C26","volume-title":"Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain","author":"American Pain Society","year":"2008","edition":"6th edn"},{"key":"key\n\t\t\t\t20180830004434_hyy046C27","volume-title":"Bonica\u2019s Management of Pain","author":"Fishman","year":"2010","edition":"4th edn"},{"key":"key\n\t\t\t\t20180830004434_hyy046C28","first-page":"661","volume-title":"Opioid Therapy in the 21st Century","author":"Fallon","year":"2014","edition":"2nd edn"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/48\/5\/442\/25536123\/hyy046.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T03:55:34Z","timestamp":1570938934000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/48\/5\/442\/4964830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,9]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,4,9]]},"published-print":{"date-parts":[[2018,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyy046","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,5]]},"published":{"date-parts":[[2018,4,9]]}}}